August 20, 2009
A lead Gardasil researcher says more complete warnings should be given to patients before the vaccine is administered. In an interview with CBS News, Dr. Diane Harper also criticized Merck & Co.’s aggressive marketing of Gardasil.
As we’ve reported previously, Dr. Harper has dedicated two decades of her career to research on the Human Papillomavirus (HPV), the virus that causes cervical cancer. She served as a researcher on study trials for Gardasil and another HPV vaccine, Cervarix. Dr. Harper has also been a paid speaker and consultant for Merck.
Dr. Harper’s ties to Merck and Gardasil have not affected her objectivity in regards to the vaccine. While Dr. Harper has said she is convinced HPV vaccines can help prevent cancers in the long-run, she has been critical in the past of Merck’s efforts to have Gardasil declared a mandatory vaccine in many states.